Patterns of metastases of prostatic ductal adenocarcinomaWeranja Ranasinghe, Brian F. Chapin, Nathan A. Brooks et al.|Cancer|2020Cited by 27
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancerEmily Hinchcliff, Amir A. Jazaeri, Cai Xu et al.|Cancer|2023Cited by 18
Randomized phase II trial of durvalumab (anti-PDL1) and tremelimumab (anti-CTLA4) administered in combination versus sequentially for the treatment of recurrent platinum-resistant non-clear cell ovarian cancer (NCT03026062)Emily Hinchcliff, Amir A. Jazaeri, Ami Patel et al.|Gynecologic Oncology|2021Cited by 8